StrokeCerebral HemorrhageIntracranial HemorrhagesBrain IschemiaCerebrovascular DisordersSubarachnoid HemorrhageIntracranial Hemorrhage, HypertensiveRisk FactorsCerebral InfarctionRiskNasal DecongestantsProspective StudiesFollow-Up StudiesCohort StudiesIschemic Attack, TransientIncidenceFactor XIIIaHemangioma, Cavernous, Central Nervous SystemPhenylpropanolamineHemorrhageBasal Ganglia HemorrhageCase-Control StudiesTreatment OutcomeFibrinolytic AgentsTime FactorsAspirinAnticoagulantsWarfarinHypertensionAge FactorsAcute DiseaseThrombolytic TherapyJapanComorbidityRegistriesProportional Hazards ModelsTissue Plasminogen ActivatorTomography, X-Ray ComputedOdds RatioRecovery of FunctionSeverity of Illness IndexRisk AssessmentRetrospective StudiesVascular MalformationsSwedenCerebral Amyloid AngiopathyAtrial FibrillationRecurrenceBrainPlatelet Aggregation InhibitorsMigraine with AuraKoreaSex DistributionImmune System DiseasesCardiovascular DiseasesMultivariate AnalysisEmbolismMyocardial InfarctionAge DistributionBrain EdemaMoyamoya DiseasePredictive Value of TestsAsian Continental Ancestry GroupRandomized Controlled Trials as TopicSex FactorsUnited StatesHospitalizationMagnetic Resonance ImagingGlasgow Coma ScalePrognosisBlood PressureSmokingMethylenetetrahydrofolate Reductase (NADPH2)Logistic ModelsStreptokinasePolymorphism, GeneticBiological MarkersChinaGenetic Predisposition to DiseaseParesisStroke, LacunarDouble-Blind MethodDatabases, FactualRegression AnalysisStroke VolumeCholesterolSurvival RateAlcohol DrinkingItalyEpidemiologic MethodsBrain InfarctionHydroxymethylglutaryl-CoA Reductase InhibitorsInfarction, Middle Cerebral ArteryIntracranial AneurysmCoronary DiseasePrevalenceCaliforniaRats, Inbred SHRGenotypeAlleles